Personalized Medical Weight Loss Programs. GLP-1 Medication, tailored by weight loss specialists, at Accessible Prices.
*Average weight loss based on 68 and 72 week clinical trials studying semaglutide (2.4 mg) and tirzepatide (10-15 mg) in patients without diabetes and with BMI ≥30, or BMI ≥27 with a weight-related health condition, the average weight loss was 15% and 20% respectively. Neither of these studies evaluated compounded semaglutide or compounded tirzepatide.